Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

Withdrawn applications

Get the latest updates from Withdrawn applications directly as they happen.

Follow now 206 followers

Latest posts

Last updated 18 days ago

Human medicines European public assessment report (EPAR): Zinmyleo, trilaciclib, Status: Application withdrawn

18 days ago

Human medicines European public assessment report (EPAR): Zinmyleo, trilaciclib, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Isembyld, apitegromab, Status: Application withdrawn

22 days ago

Human medicines European public assessment report (EPAR): Isembyld, apitegromab, Status: Application withdrawn

Withdrawn application: Dupixent, 24/06/2026

about 2 months ago

Withdrawn application: Dupixent, 24/06/2026

Human medicines European public assessment report (EPAR): Azacitidine Adienne, azacitidine, Status: Application withdrawn

about 2 months ago

Human medicines European public assessment report (EPAR): Azacitidine Adienne, azacitidine, Status: Application...

Withdrawn application: BiResp Spiromax, 27/04/2026

3 months ago

Withdrawn application: BiResp Spiromax, 27/04/2026

Withdrawn application: DuoResp Spiromax, 27/04/2026

3 months ago

Withdrawn application: DuoResp Spiromax, 27/04/2026

Human medicines European public assessment report (EPAR): Orblid, bevacizumab, Status: Application withdrawn

4 months ago

Human medicines European public assessment report (EPAR): Orblid, bevacizumab, Status: Application withdrawn

Withdrawn application: Pluvicto, 23/04/2026

5 months ago

Withdrawn application: Pluvicto, 23/04/2026

Human medicines European public assessment report (EPAR): Viokat, diazoxide choline, Status: Application withdrawn

5 months ago

Human medicines European public assessment report (EPAR): Viokat, diazoxide choline, Status: Application...

Veterinary medicines European public assessment report (EPAR): Equidormin, midazolam, Status: Application withdrawn

5 months ago

Veterinary medicines European public assessment report (EPAR): Equidormin, midazolam, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Blarcamesine Anavex, blarcamesine, Status: Application withdrawn

6 months ago

Human medicines European public assessment report (EPAR): Blarcamesine Anavex, blarcamesine, Status: Application...

Veterinary medicines European public assessment report (EPAR): Cunitraxx, fenbendazole, Status: Application withdrawn

6 months ago

Veterinary medicines European public assessment report (EPAR): Cunitraxx, fenbendazole, Status: Application withdrawn